PTC Therapeutics Inc
(NAS:PTCT)
$
44.185
-0.435 (-0.97%)
Market Cap: 3.41 Bil
Enterprise Value: 2.83 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 65/100 PTC Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021 / 12:45PM GMT
Release Date Price:
$38.75
(-0.39%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Good morning, everybody. It's a pleasure this morning to have with us our next presenting company at the Bank of America Health Care Conference, PTC Therapeutics. I've got with me several members from the PTC team that we'll be talking for the next 30 minutes or so. I'll start off by introducing CEO, Stu Peltz. Hi, Stu, how are you?
Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director
Good. Good, Tazeen. Good to be here. Thanks for having us. And I have a team with me as well. I have Emily, why don't you introduce yourself?
Emily Luisa Hill
PTC Therapeutics, Inc. - CFO
Hi, Emily Hill, CFO. Nice to see you.
Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director
And then Kylie O'Keefe.
Kylie O;Keefe
' -
Hi, lovely to see you. It's Kylie O'Keefe here, Senior Vice President of Global Commercial and Corporate
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot